InsiderLens

01 avr. 2021TENDERPandion Therapeutics, Inc.87 76460.00 USD

détention directe

01 avr. 2021OTHERPandion Therapeutics, Inc.73 789—

détention directederiv

01 avr. 2021OTHERPandion Therapeutics, Inc.28 227—

détention directederiv

05 mars 2021PURCHASEMorphic Holding, Inc.1 00070.00 USD

détention directe

08 févr. 2021GRANT_AWARDPandion Therapeutics, Inc.73 7890.00 USD

détention directederiv

21 juil. 2020PURCHASEPandion Therapeutics, Inc.1 45018.00 USD

détention directe

21 juil. 2020CONVERSIONPandion Therapeutics, Inc.7 044—

détention directe

17 juil. 2020GRANT_AWARDPandion Therapeutics, Inc.3 8060.00 USD

détention directederiv

17 juil. 2020GRANT_AWARDPandion Therapeutics, Inc.13 9350.00 USD

détention directederiv

17 juil. 2020GRANT_AWARDPandion Therapeutics, Inc.10 4860.00 USD

détention directederiv

21 juil. 2020CONVERSIONPandion Therapeutics, Inc.35 9220.00 USD

détention directederiv

18 juin 2020GRANT_AWARDMorphic Holding, Inc.12 0000.00 USD

détention directederiv

01 août 2019GRANT_AWARDMorphic Holding, Inc.24 0000.00 USD

détention directederiv

01 juil. 2019CONVERSIONMorphic Holding, Inc.1 469 950—

indirect· By S.R. One, Limited

01 juil. 2019CONVERSIONMorphic Holding, Inc.830 489—

indirect· By S.R. One, Limited

01 juil. 2019PURCHASEMorphic Holding, Inc.333 33315.00 USD

indirect· By S.R. One, Limited

01 juil. 2019CONVERSIONMorphic Holding, Inc.1 469 950—

indirect· By S.R. One, Limitedderiv

01 juil. 2019CONVERSIONMorphic Holding, Inc.830 489—

indirect· By S.R. One, Limitedderiv

06 nov. 2017PURCHASESpero Therapeutics, Inc.428 57114.00 USD

indirect· See Footnote

06 nov. 2017CONVERSIONSpero Therapeutics, Inc.606 024—

indirect· See Footnote

06 nov. 2017CONVERSIONSpero Therapeutics, Inc.328 992—

indirect· See Footnote

06 nov. 2017CONVERSIONSpero Therapeutics, Inc.246 272—

indirect· See Footnote

06 nov. 2017CONVERSIONSpero Therapeutics, Inc.244 147—

indirect· See Footnote

06 nov. 2017CONVERSIONSpero Therapeutics, Inc.1 250 0000.00 USD

indirect· See Footnotederiv

06 nov. 2017CONVERSIONSpero Therapeutics, Inc.1 483 7840.00 USD

indirect· See Footnotederiv

Goyal Vikas

Transactions récentes

Goyal Vikas

Transactions récentes